Search for: "CENTOCOR V ABBOTT LABS" Results 1 - 20 of 22
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2011, 8:19 am by Stefanie Levine
Abbott Labs set aside a $1.7 billion jury verdict in favor of the patentee (Centocor) and held the patent claims at issue were invalid for lack of written description. [read post]
28 Feb 2011, 8:19 am by Stefanie Levine
Abbott Labs set aside a $1.7 billion jury verdict in favor of the patentee (Centocor) and held the patent claims at issue were invalid for lack of written description. [read post]
21 Feb 2011, 8:13 am by Kyle Fleming
The Court’s decision follows its decision in Abbott Labs. v. [read post]
10 Jan 2012, 11:58 pm by Lawrence B. Ebert
Abbott Labs., 636 F.3d 1341, 1348 (Fed. [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
11 Jan 2012, 2:02 pm
Abbott Labs., 636 F.3d 1341, 1348 (Fed. [read post]
29 May 2014, 5:00 am
Abbott Labs, Inc., 444 F.3d 383, 387-88 (5th Cir. 2006), and Melder v. [read post]
8 Jun 2012, 10:35 am by Bexis
  We rated the decision that the Texas Supreme Court just reversed, Centocor, Inc. v. [read post]